Video: What new CRC patients need to know
Did you recently find out you or a loved one has colorectal cancer? The Alliance’s Stephanie Rouse and the Cancer Support Community's Danelle Johnston detail the top 10 things you should know about colorectal cancer diagnosis, treatment, and much more.
You can also download the printable resource guide, Top 10 Things to Know at Diagnosis.
Looking for more support? Sign up for BlueHQ, the Alliance's digital support hub, or contact our team of certified patient and family support navigators at (877) 422-2030.
Top resources
FDA approves immunotherapy for MSI-H/dMMR stage II & III rectal cancer
The U.S. Food and Drug Administration approved dostarlimab (brand name Jemperli) as the first and only immunotherapy for adults with stage II or III rectal cancer that has a biomarker called MSI-H or dMMR.
FDA approves Tecentriq for some people with stage III colon cancer
The FDA has approved Tecentriq (atezolizumab), given with chemotherapy after surgery, for people with stage III colon cancer whose tumors are mismatch repair deficient (dMMR). It’s the first immunotherapy approved for this use.
Why I answer the phone: A cancer care navigator's view
Meet Paige Edmonds, a social worker behind the Alliance's helpline — and the personal loss that led her there.